EMEA-001529-PIP02-14-M01

Key facts

Active substance
Testosterone
Therapeutic area
Endocrinology, -gynacology-fertility-metabolism
Decision number
P/0132/2018
PIP number
EMEA-001529-PIP02-14-M01
Pharmaceutical form(s)
Nasal gel
Condition(s) / indication(s)
Treatment of male hypogonadism
Route(s) of administration
Nasal use
Contact for public enquiries
Acerus Pharmaceuticals SRL
Tel.: +1 4166790776
E-mail: nbryson@aceruspharma.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating